[1] Saag MS,Grayb-ll RJ,Larsen RA,et al.Practice guidline for the management of cryptococceai disease[J].Clin Infect Dis,2000,30(4):710-718. [2] Dromer F,Mathoulin-Pélissier S,Launay O,et al.Determinants of disease presentation and outcome during oryptococcosis:the CryptoA/D study[J].PLoS Med,2007,4(2):21. [3] Lortholary O,Poizat G,Zeller V,et al.Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy[J].AIDS,2006,20(17):2183-2191. [4] Perfect JR,Dismukes WE,Dromer F,et al.Clinical practice guidelines for the management of cryptococcal disease:2010 update by the infectious diseases society of America[J].Clin Infect Dis,2010,50(3):291-322. [5] 温海.隐球菌感染诊治专家共识[J].中国真菌学杂志,2010,4(2):65-68. [6] 张齐龙,邱作兴,雷建平,等.脑池引流脑脊液治疗隐球菌性脑膜炎的临床价值探讨[J].中国真菌学杂志,2006,1(5):276-278. [7] 杨玉仙,赖善国,李水彬,等.持续引流脑脊液并鞘内注药治疗隐球菌性脑膜炎17例临床疗效观察[J].脑与神经疾病杂志,2004,12(2):127-129. [8] 顾菊林,温海,陈江汉,等.腰穿置管引流脑脊液加鞘内注药治疗隐球菌性脑膜炎:附6例报告[J].中国麻风皮肤病杂志,2006,22(9):744-745. |